ABIVAX Société Anonyme (0RA9.L)

13.94 -0.22 (-1.53%) As of 05:25PM BST. Market open.

ABIVAX Société Anonyme

7-11 boulevard Haussmann
Paris 75009
France
33 1 53 83 09 63
https://www.abivax.com

Sector(s): 
Industry: 
Full-time employees: 61

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Marc M. P. de Garidel M.B.A.	CEO & Interim Chair of Board	793.97k	N/A	1958
Dr. Philippe Pouletty M.D., Ph.D.	Founder & Director	N/A	N/A	1958
Mr. Didier Blondel	EVP, CFO & Board Secretary	N/A	N/A	1964
Mr. Didier Scherrer Ph.D.	Chief Scientific Officer	N/A	N/A	1970
Mr. Patrick Malloy	Senior Vice President of Investor Relations	N/A	N/A	N/A
Ms. Ida Hatoum	Chief People Officer	N/A	N/A	1975
Mr. Pierre Courteille M.B.A.	Chief Business Officer	N/A	N/A	1969
Mr. Jérôme Denis	Executive Vice President of Process Development & Manufacturing	N/A	N/A	N/A
Mr. Sheldon Sloan M.D.	Chief Medical Officer	N/A	N/A	1959
Mr. Michael Ferguson B.S., M.B.A.	Chief Commercial Officer	N/A	N/A	1978

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Corporate governance

ABIVAX Société Anonyme’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.